why choose us

Clinical Trials Search

Showing 16,670 of 132,963 result(s)
A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Specified dose on specified days

Date: 2023-01-06

Improving Cancer Screening and Follow-up in Community Health Centers

Status: Completed

Condition: Breast Cancer Screening

Interventions: The intervention is implementation of new population health management tools that may better leverage patient navigation and other staff resources to

Date: 2023-01-06

A Study of STAR-0215 in Participants With Hereditary Angioedema

Status: Completed

Condition: Hereditary Angioedema

Interventions: STAR-0215 will be administered as a subcutaneous bolus injection.

Date: 2023-01-06

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Status: NOT_YET_RECRUITING

Condition: Advanced Urothelial Carcinoma

Interventions: intravenous infusion (IV) at 60 mg on Day 1, 8 and 15 of each 4-week treatment cycle for up to 26 cycles

Date: 2023-01-06

IMM60 and Pembrolizumab in Melanoma and NSCLC

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: IMM60, every 3 weeks for up to 6 cycles, intravenous (IV) infusion

Date: 2023-01-06

Improving Cognition With Neurodegradation Countermeasure

Status: COMPLETED

Condition: Hemodynamics

Interventions: Participants will take Teacrine and caffeine then an hour later perform an intense interval exercise protocol followed by cognitive tests.

Date: 2023-01-06

Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

Status: Completed

Condition: Vancomycin-Resistant Enterococcal Colonization

Interventions: A cocktail of lytic Enterococcus-specific bacteriophages orally administered with sodium bicarbonate solution

Date: 2023-01-06

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

Status: Completed

Condition: Carcinoma, Non-Small-Cell Lung

Interventions: Immunotherapy

Date: 2023-01-06

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Status: ACTIVE_NOT_RECRUITING

Condition: Alzheimer Disease

Interventions: HPMC (vegetarian source) capsule shells

Date: 2023-01-06

Weight Discrimination and Poor Cardiovascular Health

Status: Completed

Condition: Obesity

Interventions: In the experimental condition, participants will learn that their group members are biased against overweight people but not elderly or racial;et

Date: 2023-01-06